Literature DB >> 22124920

[Institutional support as a method of analysis-intervention in the context of public health policies: the experience in a general hospital].

Maria Elizabeth Barros de Barros1, Carla Ribeiro Guedes, Monica Maria Raphael Roza.   

Abstract

The article addresses the elaboration of a method for analysis/intervention in the sphere of public health policies. It describes the introduction of the National Humanization Policy of the Unified Health System (SUS) in a general hospital. It proposes institutional support expressed as a method for doing things that seeks the creation of group action, work process analysis and involves examining work management methods. It relies on promotion of health, which implies the production of subjects. The promotion of health is a networking process that involves individuals, work processes, knowledge and power. The challenge of supporting this network is to foster the exercise of the role of individuals and summon the inherent creative potential of life for the construction of new ways of work management that are not new forms of subjection. The study aims to show that by means of institutional support it is possible to bring to the fore the forces involved in the promotion of health and thereby summon the groups for an analysis of its implications. The effects produced indicate that this is a powerful strategy for the intervention of work processes within the scope of public health policies.

Mesh:

Year:  2011        PMID: 22124920

Source DB:  PubMed          Journal:  Cien Saude Colet        ISSN: 1413-8123


  1 in total

1.  Institutional and matrix support and its relationship with primary healthcare.

Authors:  Alaneir de Fátima dos Santos; Antônio Thomaz Gonzaga da Matta Machado; Clarice Magalhães Rodrigues dos Reis; Daisy Maria Xavier Abreu; Lucas Henrique Lobato de Araújo; Simone Cristina Rodrigues; Ângela Maria de Lourdes Dayrell de Lima; Alzira de Oliveira Jorge; Délcio Fonseca Sobrinho
Journal:  Rev Saude Publica       Date:  2015-08-11       Impact factor: 2.106

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.